NCT04685993Phase 2Completed

A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial

Study sponsor: Lipocine Inc. · LPCN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-03-01Actual
Enrollment · participants25Actual
Source updated2024-07-17Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview